NorthRock Partners’s Rockwell Medical RMTI Stock Holding History

NorthRock Partners’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-170	Closed	-$20K	–	250
2020 Q3	$20K	Buy	+170	New	+$29.4K	﹤0.01%	222

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

NorthRock Partners's RMTI Position: Q4 2020 in Review

NorthRock Partners sold out of Rockwell Medical (RMTI) in Q4 2020, closing a stake of 170 shares — an estimated $20K sold.

NorthRock Partners first reported a position in RMTI in Q3 2020 and held it in 1 quarter. The position peaked at $20K in Q3 2020. 91 funds tracked by Wall St. Rank hold RMTI as of Q4 2020.

NorthRock Partners reported no remaining Rockwell Medical position as of Q4 2020 after selling out during the quarter.
NorthRock Partners sold 170 Rockwell Medical shares in Q4 2020, an estimated $20K.
NorthRock Partners first reported a position in Rockwell Medical in Q3 2020 and held it in 1 quarter.
NorthRock Partners's Rockwell Medical position peaked at $20K in Q3 2020.
91 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2020.

Based on NorthRock Partners's 13F filing for Q4 2020, filed 8 Feb 2021.